Parkin D M. Global cancer statistics in the year 2000 [J]. {H}LANCET ONCOLOGY, 2001(2):533.
|
Sakaguchi S, Yamaguchi T, Nomura T. Regulatory T cells and immune tolerance [J]. {H}CELL, 2008, (133):775.
|
Zou W. Regulatory T cells, tumour immunity and immunotherapy [J]. {H}Nature reviews Immunology, 2006(6):295.
|
Mougiakakos D, Choudhury A, Lladser A. Regulatory T cells in cancer [J]. {H}Advances in Cancer Research, 2010, (107):57.
|
Saknguchi S, Sakaguchi N, Asano M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [J]. {H}Journal of Immunology, 1995(3):1151.
|
HoriS, NomuraT, Sakaguchi S. Controlof regulatory T cell development by the transcription factor Foxp3 [J]. {H}SCIENCE, 2003, (5609):1057.
|
Wang Y, Ma Y, Fang Y. Regulatory T cell:a protection for tumour cells [J]. {H}Jourmal Cell Mol Med, 2012(3):425.
|
Mizukami Y, Kono K, Kawaguchi Y. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3 + regulatory T cells in gastric cancer [J]. {H}International Journal of Cancer, 2008, (10):2286.
|
Gobert M, Treilleux I, Bendriss-Vermare N. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome [J]. {H}CANCER RESEARCH, 2009(5):2000.
|
Zhang W, Wu K, He W. Transforming growth factor beta 1 plays an important role in inducing CD4+ 、CD25+ forhead box P3(+) regulatory T cells by mast cells [J]. {H}CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010(3):490.
|
Liu Y, Zhang P, Li J. A critical function for TGF-beta signaling in the development of natural CD4+ CD25+ Foxp3 +regulatory T cells [J]. {H}Nature Immunology, 2008(6):632.
|
Cao M, Cabrera R, Xu Y. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4 + 、CD25 + regulatory T cells [J]. {H}Laboratory Investigation, 2007(6):582.
|
Camisaschi C, Casati C, Rini F. LAG-3 expression defines a subset of CD4+ 、CD25 (high)Foxp3(+) regulatory T cells that are expanded at tumor sites [J]. {H}Journal of Immunology, 2010, (11):6545.
|